Dr. Anthony Levitt
Dr. Nir Lipsman
New Horizons in Brain Health
November 14th, 1:00-3:00 pm
The brain remains the last frontier, the most complex and challenging organ in the human body to understand and treat. Psychiatrist and researcher Dr. Anthony Levitt offers an overview of the interdisciplinary approach to brain disorders at Sunnybrook’s Hurvitz Brain Sciences program, including recent advances in psychiatry. Neurosurgeon and scientist Dr. Nir Lipsman shares an update on Sunnybrook’s world‐leading research on using focused ultrasound to offer non‐surgical treatment for major brain issues, including essential tremor and Alzheimer’s disease.
Bio - Dr. Anthony Levitt
Dr. Anthony Levitt was psychiatrist‐in‐chief at Sunnybrook Health Sciences Centre for a decade prior to being appointed chief of the Hurvitz Brain Sciences Program in 2013. His research focuses on mood disorders, including seasonal depression, adolescent depression and the impact of thyroid hormones on mood. He is committed to public and medical education, to improving recognition of mood disorders by health‐care professionals and to expanding access to care for people with mood disorders in the community. Dr. Levitt was instrumental in establishing the Family Navigation Project in 2013 at Sunnybrook, which connects families in need with appropriate mental health services, and serves as the program’s medical director.
Bio - Dr. Nir Lipsman
Dr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Research Institute, where he helped lead Canada’s first clinical trials of focused ultrasound to treat essential tremor. He is now developing trials to investigate the use of focused ultrasound for the treatment of obsessive‐compulsive disorder, depression and Alzheimer’s disease. These first‐in‐human trials, in collaboration with scientific director Dr. Kullervo Hynynen, represent the latest advances in MRI‐guided focused ultrasound. His research interests include novel neuromodulation strategies to target sites within the central nervous system using electrical stimulation or drugs to address neurological and psychiatric conditions that are difficult to treat.